logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PPP-5. Potency of cannabis products at retail level, 2007 [see all tables in this series...]

Part (iii) Sampling frame / Type of study

CountrySampling frame / Type of study
BulgariaAll seizures / routine analysis of seizures
Czech RepublicAll seizures / routine analysis of seizures
GermanyAll seizures / routine analysis of seizures
EstoniaAll seizures / routine analysis of seizures
France-AAll seizures / monitoring system
France-BAll seizures / monitoring system
LuxembourgAll seizures / monitoring system
HungaryAll seizures submitted for analysis of over 8 g / resin seizures of over 25 g / routine analysis of seizures
MaltaAll seizures / monitoring system
NetherlandsUser's level: random test purchases in coffee shops / monitoring system
AustriaSeizures under a specific threshold/Seizures when suspicion about the substance / test purchases at street level / routine analysis of seizures
PolandNot all seizures (includes material from cultivations) / routine analysis of seizures
PortugalRandom selected sample of seizures of under 1 g / routine analysis of seizures
SloveniaAll seizures: random selection / routine analysis of seizures
SlovakiaAll seizures / routine analysis of seizures
FinlandTHC purity is measured only when herbal cannabis sample amount is >150 g and the purity test is specially requested / monitoring system
United KingdomAll seizures submitted for analysis by police forces / routine analysis of seizures

(see the help page for information about formats etc.)

Page last updated: Wednesday, 01 July 2009